Metraipolis › archive › dc_bcf05ef89f9c

The anti-CD33 antibody drug conjugate gemtuzumab ozogamicin depletes and functionally resets CD33+ myeloid-derived suppressor cells in patients with… — Europe PMC PMID:42314073

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42314073
DOI
10.1093/jleuko/qiag083
License (as archived)
solo-consultazione
Archived
2026-10-08T10:14:01.251Z
SHA-256 of the archived text
db1ad178ec6d10c308b3da21cf548b9019ae2b517519ccfa15e67974091255bc
Stable URL of this page
https://metraipolis.com/documento/dc_bcf05ef89f9c

How to cite

The anti-CD33 antibody drug conjugate gemtuzumab ozogamicin depletes and functionally resets CD33+ myeloid-derived suppressor cells in patients with… — Europe PMC PMID:42314073 — Europe PMC (en), https://europepmc.org/article/MED/42314073 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bcf05ef89f9c (Metraipolis archive dc_bcf05ef89f9c, sha256 db1ad178ec6d10c308b3da21cf548b9019ae2b517519ccfa15e67974091255bc)
BibTeX
@misc{dcbcf05ef89f9c,
  title = {The anti-CD33 antibody drug conjugate gemtuzumab ozogamicin depletes and functionally resets CD33+ myeloid-derived suppressor cells in patients with… — Europe PMC PMID:42314073},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42314073},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bcf05ef89f9c; sha256 db1ad178ec6d10c308b3da21cf548b9019ae2b517519ccfa15e67974091255bc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42314073. Agents can read the archived copy with the MCP tool read_document.